Tag: headache

Repeated Ketamine Infusions Linked to Rapid Relief of PTSD

Repeated intravenous infusions of ketamine provide rapid relief for patients with posttraumatic stress disorder (PTSD), new research suggests. In what investigators are calling the first...

Dexamethasone Harmful in Chronic Subdural Hematoma

A commonly used treatment for chronic subdural hematoma appears to be doing more harm than good, a new randomized trial has shown. The results show...

What Happened When the Only ER Doctor in a Rural Town Got COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Kurt Papenfus is the lone full-time emergency room doctor in Cheyenne...

Improvements in Chronic Hand Eczema Seen With Oral Gusacitinib

Gusacitinib, a novel oral inhibitor of multiple inflammatory pathways, achieved rapid and clinically meaningful improvement in corticosteroid-refractory moderate to severe chronic hand eczema in a...

Time to Discuss the Unpleasant Side Effects of COVID Shots?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A health worker injects a woman during clinical trials for a...

Sleep Apnea Found to Impact Pain Severity in Younger Adults

Sleep specialists might want to take a closer look at the connections between obstructive sleep apnea, chronic pain, and reported pain intensity in younger patients....

Delgocitinib Successful for Hand Eczema in Phase 2b Trial

Delgocitinib cream shows a dose-dependent response in easing chronic hand eczema, a common and difficult-to-treat disorder for which few other topical options are available, new...

Pandemic Stress Takes Its Toll

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.   In late March, shortly after New York state closed nonessential...

HIT-6 Helps Track ‘Meaningful Change’ in Chronic Migraine

A more than 6-point improvement in Headache Impact Test (HIT-6) total score and a 1-2 category improvement in item-specific scores of HIT-6 appeared to be...

Positive Topline Results for New Cervical Dystonia Treatment

DaxibotulinumtoxinA for Injection for treatment for cervical dystonia met the primary and all secondary endpoints in the phase 3 ASPEN-1 study, according to topline results...

Once-Weekly Investigational MK-8507 Potent Even at Low Doses

A single dose of MK-8507, an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), reduced HIV-1 viral loads for at least 1 week with efficacy comparable to...

First Confirmed Cases of COVID-19 Reinfections in US

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A 25-year-old man from Nevada and a 42-year-old man in Virginia...

No Migraine ‘Rebound’ Stopping Clopidogrel After ASD Closure

Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months...

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

“It is time that the prodromal phase of multiple sclerosis is formally recognized.” That was the conclusion of Helen Tremlett, PhD, delivering the opening plenary...

Distinguishing COVID-19 From Flu in Kids Remains Challenging

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. For children with COVID-19, rates of hospitalization, ICU admission, and ventilator...

When Viruses Collide: Flu Season During Pandemic

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The medical community is about to find out how prepared it...

Smoking Linked to Increased Risk for Unruptured Aneurysm

Women who smoke cigarettes are at increased risk for intracranial aneurysms, new research suggests. In a case-control study of more than 500 women between the...

Galcanezumab Looks Promising for Treatment-Resistant Migraine

The calcitonin gene-related peptide monoclonal antibody galcanezumab (Emgality, Lilly) compared favorably to placebo for reducing the number of average monthly migraine days in a new...

Why We Can’t Test Our Way Out of This

What your doctor is reading on Medscape.com: MAY 06, 2020 — At the moment, society is locked down in an attempt to reduce...

EU Panel Backs Triple Combo Asthma Inhaler With Digital Sensor

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Enerzair Breezhaler, the first triple-combination asthma...

Two Rare Neurologic Conditions Linked to COVID-19

What your doctor is reading on Medscape.com: APRIL 29, 2020 — Two rare neurologic conditions in patients hospitalized with COVID-19 add more evidence...

After Battling Flint Water Crisis, Doc Faces COVID Fight

Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Mona Hanna-Attisha, MD, MPH, a pediatrician nationally recognized for her efforts in exposing...